PEAQX

From WikiMD's WELLNESSPEDIA


Overview[edit]

PEAQX is a chemical compound known for its role as a selective antagonist of the AMPA receptor, a type of ionotropic glutamate receptor in the central nervous system. It is primarily used in neuroscience research to study the function of AMPA receptors and their involvement in synaptic transmission and plasticity.

Chemical Structure[edit]

Chemical structure of PEAQX

PEAQX is a synthetic compound with a complex chemical structure that allows it to selectively bind to AMPA receptors. Its molecular formula is C18H18N4O4, and it is characterized by its ability to inhibit the activity of these receptors without affecting other types of glutamate receptors, such as NMDA receptors.

Mechanism of Action[edit]

PEAQX functions by binding to the AMPA receptor at the glutamate binding site, preventing the receptor from being activated by its natural ligand. This inhibition blocks the flow of sodium and calcium ions through the receptor channel, thereby modulating excitatory synaptic transmission in the brain. This property makes PEAQX a valuable tool in the study of neurophysiology and neuropharmacology.

Applications in Research[edit]

PEAQX is widely used in laboratory settings to investigate the role of AMPA receptors in various neurological processes. It is particularly useful in studies of long-term potentiation (LTP) and long-term depression (LTD), which are cellular mechanisms underlying learning and memory. By selectively blocking AMPA receptors, researchers can better understand their contribution to these processes and explore potential therapeutic targets for neurological disorders.

Safety and Handling[edit]

As with many research chemicals, PEAQX should be handled with care. It is important to follow appropriate safety protocols, including the use of personal protective equipment (PPE) and working in a well-ventilated area. Researchers should consult the material safety data sheet (MSDS) for detailed information on handling and potential hazards.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=PEAQX&oldid=6289893"